196 related articles for article (PubMed ID: 30819134)
1. Primary paediatric epidural sarcomas: molecular exploration of three cases.
Low SYY; Kuick CH; Seow WY; Bte Syed Sulaiman N; Chen H; Lian DWQ; Chang KTE; Tan EEK; Soh SY; Tan GIL; Ng LP; Seow WT; Low DCY
BMC Cancer; 2019 Feb; 19(1):182. PubMed ID: 30819134
[TBL] [Abstract][Full Text] [Related]
2. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-NCOA2 fusion.
Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A
Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896
[TBL] [Abstract][Full Text] [Related]
3. Primary Spinal Epidural CIC-DUX4 Undifferentiated Sarcoma in a Child.
Donahue JE; Yakirevich E; Zhong S; Treaba DO; Lakis NS; Ali SM; de la Monte SM; Mangray S
Pediatr Dev Pathol; 2018; 21(4):411-417. PubMed ID: 28474974
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal chondrosarcoma diagnosed on FISH for HEY1-NCOA2 fusion gene.
Moriya K; Katayama S; Onuma M; Rikiishi T; Hosaka M; Watanabe M; Hasegawa T; Sasahara Y; Kure S
Pediatr Int; 2014 Oct; 56(5):e55-7. PubMed ID: 25336010
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.
Wang L; Motoi T; Khanin R; Olshen A; Mertens F; Bridge J; Dal Cin P; Antonescu CR; Singer S; Hameed M; Bovee JV; Hogendoorn PC; Socci N; Ladanyi M
Genes Chromosomes Cancer; 2012 Feb; 51(2):127-39. PubMed ID: 22034177
[TBL] [Abstract][Full Text] [Related]
7. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation.
Milione M; Gasparini P; Sozzi G; Mazzaferro V; Ferrari A; Casali PG; Perrone F; Tamborini E; Pellegrinelli A; Gherardi G; Arrigoni G; Collini P; Testi A; De Paoli E; Aiello A; Pilotti S; Pelosi G
Histopathology; 2014 Jun; 64(7):1014-26. PubMed ID: 24898918
[TBL] [Abstract][Full Text] [Related]
8. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma.
Lee AF; Hayes MM; Lebrun D; Espinosa I; Nielsen GP; Rosenberg AE; Lee CH
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):233-8. PubMed ID: 21084965
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal chondrosarcoma of the head and neck with HEY1::NCOA2 fusion: A clinicopathologic and molecular study of 13 cases with emphasis on diagnostic pitfalls.
Xu B; Rooper LM; Dermawan JK; Zhang Y; Suurmeijer AJH; Dickson BC; Demicco EG; Antonescu CR
Genes Chromosomes Cancer; 2022 Nov; 61(11):670-677. PubMed ID: 35672279
[TBL] [Abstract][Full Text] [Related]
10. Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma.
Panagopoulos I; Gorunova L; Bjerkehagen B; Boye K; Heim S
Oncol Rep; 2014 Jul; 32(1):40-4. PubMed ID: 24839999
[TBL] [Abstract][Full Text] [Related]
11. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
12. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
Szurian K; Kashofer K; Liegl-Atzwanger B
Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
[TBL] [Abstract][Full Text] [Related]
13. Novel exon-exon breakpoint in
Loke BN; Lee VKM; Sudhanshi J; Wong MK; Kuick CH; Puhaindran M; Chang KTE
J Clin Pathol; 2017 Aug; 70(8):697-701. PubMed ID: 28137728
[TBL] [Abstract][Full Text] [Related]
14. NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma.
Yoshida KI; Machado I; Motoi T; Parafioriti A; Lacambra M; Ichikawa H; Kawai A; Antonescu CR; Yoshida A
Am J Surg Pathol; 2020 Jun; 44(6):719-728. PubMed ID: 31972596
[TBL] [Abstract][Full Text] [Related]
15. Primary spinal intradural mesenchymal chondrosarcoma with detection of fusion gene HEY1-NCOA2: A paediatric case report and review of the literature.
Andersson C; Osterlundh G; Enlund F; Kindblom LG; Hansson M
Oncol Lett; 2014 Oct; 8(4):1608-1612. PubMed ID: 25202377
[TBL] [Abstract][Full Text] [Related]
16. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
[TBL] [Abstract][Full Text] [Related]
17. Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.
Qi W; Rosikiewicz W; Yin Z; Xu B; Jiang H; Wan S; Fan Y; Wu G; Wang L
J Pathol; 2022 Aug; 257(5):579-592. PubMed ID: 35342947
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of molecular genetics to paediatric sarcomas.
Slater O; Shipley J
J Clin Pathol; 2007 Nov; 60(11):1187-94. PubMed ID: 17468291
[TBL] [Abstract][Full Text] [Related]
19. Novel low-grade renal spindle cell neoplasm with HEY1::NCOA2 fusion that is distinct from mesenchymal chondrosarcoma.
Miller TI; Mantilla JG; Wang W; Liu YJ; Tretiakova M
Genes Chromosomes Cancer; 2023 Mar; 62(3):171-175. PubMed ID: 36416671
[TBL] [Abstract][Full Text] [Related]
20. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
